C-Reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study

SIMPLE SUMMARY: Most patients with locally advanced rectal cancer present resistance or a moderate response to neoadjuvant chemoradiotherapy (nCRT), which is considered the standard of care. To select patients who could benefit from nCRT, while avoiding unnecessary treatment-induced toxicity and sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Aires, Fátima, Rodrigues, Darlene, Lamas, María Piñeiro, Herdeiro, Maria Teresa, Figueiras, Adolfo, Oliveira, Maria José, Marques, Margarida, Pinto, Ana Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833484/
https://www.ncbi.nlm.nih.gov/pubmed/35158759
http://dx.doi.org/10.3390/cancers14030491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833484/
https://www.ncbi.nlm.nih.gov/pubmed/35158759
http://dx.doi.org/10.3390/cancers14030491

Ejemplares similares